Table 3.
Tumor site | Men | Women | ||
<65 years (billion $) | ≥65 years (billion $) | <65 years (billion $) | ≥65 years (billion $) | |
Lung | 66.1 | 82.3 | 50.1 | 72.3 |
Breast | 51.3 | 33.9 | ||
Prostate | 5.5 | 29.3 | ||
Colorectal | 20.7 | 24.1 | 17.2 | 28.8 |
Pancreas | 12.1 | 12.3 | 8.9 | 16.6 |
Ovary | — | — | 13.9 | 13.8 |
Leukemia | 10.7 | 9.8 | 8.4 | 9.1 |
Lymphoma (non-Hodgkin) | 10.0 | 9.6 | 6.8 | 11.1 |
Esophagus | 9.4 | 7.7 | 1.9 | 3.1 |
Urinary bladder | 3.4 | 7.7 | 1.4 | 4.2 |
Liver | 9.6 | 6.4 | 3.6 | 5.1 |
Kidney | 7.2 | 5.8 | 3.4 | 4.6 |
Gastric | 6.1 | 5.9 | 3.8 | 5.0 |
Head and neck | 7.8 | 5.3 | 2.4 | 2.9 |
Brain and ONS | 11.5 | 4.2 | 8.6 | 4.6 |
Cervix | — | — | 8.2 | 2.2 |
Corpus uteri | — | — | 5.2 | 6.9 |
Melanoma of the skin | 6.0 | 3.2 | 3.8 | 2.2 |
Lymphoma (Hodgkin) | 1.4 | 0.4 | 1.1 | 0.4 |
Testis | 1.1 | 0.1 | — | — |
All cancers | 222.4 | 245.8 | 227.9 | 264.5 |
Tumor sites are listed from highest to lowest sex-specific age-adjusted mortality rate. — = not available or not applicable to this population; ONS = other neurologic sites. Value of life lost was estimated using a previously published value of 1 year of life ($150 000) applied to the person-years of life lost estimate for each tumor site. All value of life lost estimates were discounted by 3% annually and reported in real dollars.